Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Watermark Research Partners is a clinical research site network that specializes in conducting Phase II through Phase IV clinical trials for the pharmaceutical, biotechnology, and medical device industries. Founded in 2002 and headquartered in Florida, the company operates multiple dedicated research facilities known for high-quality data collection and rapid patient recruitment. Their therapeutic expertise includes internal medicine, neurology, vaccines, and dermatology. In July 2019, the company was acquired by Velocity Clinical Research, integrating its sites into one of the largest site management organizations in the United States. The organization continues to provide essential clinical trial services as part of the broader Velocity network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Watermark Research Partners.